Zonisamide as a neuroprotective agent in an adult gerbil model of global forebrain ischemia: A histological, in vivo microdialysis and behavioral study

Brain Research

Volumn 770, Issue 1-2, 1997, Pages 115-122

  Owen, Andrew J ^b   Ijaz, Sadiq ^b   Miyashita, Hiro ^b   Wishart, Tom ^b   Howlett, Wendy ^b   Shuaib, Ashfaq ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Behavior; Gerbil; Global ischemia; Glutama te; Hippocampus; Histology; Microdialysis; Neuroprotection; Zonisamide

Indexed keywords

ZONISAMIDE;

ANIMAL MODEL; ARTICLE; BRAIN ISCHEMIA; BRAIN PROTECTION; CONTROLLED STUDY; DRUG EFFECT; FOREBRAIN; GERBIL; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTICONVULSANTS; BEHAVIOR, ANIMAL; DISEASE MODELS, ANIMAL; GERBILLINAE; GLUTAMIC ACID; HIPPOCAMPUS; ISCHEMIC ATTACK, TRANSIENT; ISOXAZOLES; MALE; MAZE LEARNING; MICRODIALYSIS; NEUROPROTECTIVE AGENTS; PROSENCEPHALON; SILVER STAINING;

EID: 0030771536     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)00789-0     Document Type: Article

References (53)

1. Baldwin H., Williams J., Snares M., Ferreira T., Cross A., Green A. Attenuation by chlormethiazole administration of the rise in extracellular amino acids following focal ischemia in the cerebral cortex of the rat. Br. J. Pharmacol. 112:1994;188-194.
2. Bean B. Classes of calcium channels in vertebrate cells. Annu. Rev. Physiol. 51:1989;367-384.
3. Benveniste H., Drejer J., Schousboe A., Diemer N. Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J. Neurochem. 43:1984;1369-1374.
4. Bonnekoh P., Barbier A., Oschlies U., Hossman K. Selective vulnerability in the gerbil hippocampus: morphological changes after 5-min ischemia and long survival times. Acta Neuropathol. 80:1990;18-25.
5. Buchan A., Gertler S., Li H., Xue D., Huang Z., Chaundy K., Barnes K., Lesiuk H. A selective N-type calcium channel blocker prevents CA1 injury 24 h following severe forebrain ischemia and reduces infarction following focal ischemia. J. Cereb. Blood Flow Metab. 14:1994;903-910.
6. Busto R., Dietrich W., Globus M., Valdés I., Scheinberg P., Ginsberg M. Small differences in intraischemic brain temperature critically determine the extent of ischemic neuronal injury. J. Cereb. Blood Flow Metab. 7:1987;729-738.
7. Busto R., Mordecai Y., Globus M., Dietrich W., Martinez E., Valdés I., Ginsberg M. Effect of mild hypothermia on ischemia induced release of neurotransmitter and free fatty-acids in rat brain. Stroke. 20:1989;904-910.
8. Choi D., Rothman S. The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Annu. Rev. Neurosci. 13:1990;171-182.
9. Corbett D., Evans S., Nurse S. Impaired acquisition of the Morris water maze following global ischemia in the gerbil. Neuroreport. 3:1992;204-206.
10. Crain B., Westerkam W., Harrison A., Nadler J. Selective neuronal death after transient forebrain ischemia in the Mongolian gerbil: a silver impregnation study. Neuroscience. 27:1988;387-402.
11. Dietrich W., Busto R., Alonso O., Globus M., Ginsberg M. Intraischemic but not postischemic brain hypothermia protects chronically following global forebrain ischemia in rats. J. Cereb. Blood Flow Metab. 13:1993;541-549.
12. Donzanti B., Yamamoto B. An improved and rapid HPLC-EC method for the isocratic separation of amino acid neurotransmitters from brain tissue and microdialysis perfusates. Life Sci. 43:1988;913-922.
13. Gallyas F., Wolff J., Bottcher H., Zaborsky L. A reliable and sensitive method to localize axonal damage after axotomy. Stain Technol. 55:1988;291-297.
14. Gallyas F., Wolff J., Bottcher H., Zaborsky L. A reliable and sensitive method to localize terminal degeneration and lysosomes in the central nervous system. Stain Technol. 55:1988;299-306.
15. Ginsberg M., Sternau L., Globus M., Dietrich W., Busto R. Therapeutic modulation of brain temperature: relevance to ischemic brain injury. Cerebrovasc. Brain Metab. Rev. 4:1992;189-225.
16. Hammond E., Perchalski R., Wilder B. Neuropharmacology of zonisamide, a new antiepileptic drug. Gen. Pharmacol. 18:1987;303-307.
17. Hara H., Sukamoto T., Kogure K. Mechanism and pathogenesis of ischemia induced neuronal damage. Prog. Neurobiol. 40:1993;645-670.
18. Hayakawa T., Higuchi Y., Nigami H., Hatttori H. Zonisamide reduces hypoxic-ischemic brain damage in neonatal rats irrespective of its anticonvulsive effect. Eur. J. Pharmacol. 257:1994;131-136.
19. Heron A., Lekieffre D., Peillet E., Lasbennes F., Seylaz J., Plotkine M., Boulu R. Effects of an A1 adenosine receptor agonist on the neurochemical, behavioural and histological consequences of ischemia. Brain Res. 641:1995;217-224.
20. Ikeda M., Nakazawa T., Abe K., Kaneko T., Yamatsu K. Extracellular accumulation of glutamate in the hippocampus induced by ischemia is not calcium dependent: in vitro and in vivo evidence. Neurosci. Lett. 96:1989;202-206.
21. Kirino T. Delayed neuronal death in the gerbil hippocampus following ischemia. Brain Res. 239:1981;57-69.
22. Kumagai N., Seki T., Yamawaki H., Suzuki N., Kimiya S., Yamada T., Hara M., Hashimoto R., Takuma Y., Hirai K. Monotherapy for childhood epilepsies with zonisamide. Jpn. J. Psychiatry Neurol. 45:1991;357-359.
23. Lal S., Shuaib A., Ijaz S. Baclofen is cytoprotective to cerebral ischemia in gerbils. Neurochem. Res. 20:1995;115-119.
24. Leach M., Swan J., Eisenthal D., Dopson M., Nobbs M. BW 619C89, a glutamate release inhibitor, protects against focal cerebral ischemic damage. Stroke. 24:1993;1063-1067.
25. Lekieffre D., Meldrum B. The pyrimidine-derivative BW 1003C87, protects CA1 and striatal neurons following transient severe forebrain ischemia in rats. A microdialysis and histological study. Neuroscience. 56:1993;93-99.
26. Leppik I., Willmore L., Homan R., Fromm G., Oommem K., Penry J., Sackellares J., Smith D., Lesser R., Wallace J. Efficacy and safety of zonisamide: result of a multicenter study. Epilepsy Res. 14:1993;165-173.
27. Lipton S., Rosenberg P. Excitatory amino acids as a final common pathway for neurologic disorders. New Engl. J. Med. 330:1994;613-622.
28. W. Loskota, P. Lomax, M. Verity, A Stereotaxic Atlas of the Mongolian Gerbil Brain (Meriones unguiculatus), Ann Arbor Science Publishers, Ann Arbor, MI, 1974.
29. + channel modulator and glutamate release inhibitor in cultured rat cerebellar neurons and in gerbil global brain ischemia. Stroke. 25:1994;2476-2482.
30. Meldrum B. Cytoprotective therapies in stroke. Curr. Opin. Neurol. 8:1995;15-23.
31. Meldrum B., Swan J., Leach M., Millan M., Gwinn R., Kadota K., Graham S., Chen J., Simon R. Reduction of glutamate release and protection against ischemic brain damage by BW 1003C87. Brain Res. 593:1992;1-6.
32. Morris R. Development of a water-maze procedure for studying spatial learning in the rat. J. Neurosci. Methods. 11:1984;47-60.
33. Muir K., Lees K. Clinical experience with excitatory amino acid antagonist drugs. Stroke. 26:1995;503-513.
34. Nakatsuji K., Matsuno Y., Nakamura N., Fujitani B., Ito T., Kadokawa T. General pharmacology of the novel antiepileptic compound zonisamide. Drug Res. 10:1987;1131-1136.
35. Nicholls D., Attwell D. The release and uptake of excitatory amino acids. Trends Pharmacol. Sci. 11:1990;462-468.
36. Nunn J., Hodges H. Cognitive deficits induced by global cerebral ischemia: relationship to brain damage and reversal by transplants. Behav. Brain Res. 65:1994;1-31.
37. Nunn J., LePeillet E., Netto C., Hodges H., Gray J., Meldrum B. Global ischemia: hippocampal pathology and spatial deficits in the water maze. Behav. Brain Res. 62:1994;41-54.
38. Rock D., MacDonald R., Taylor C. Blockade of sustained repetitive action potentials in cultured spinal cord neurons by zonisamide (AD 810, CI 912), a novel anticonvulsant. Epilepsy Res. 3:1989;138-143.
39. Schauf C. Zonisamide enhances slow sodium inactivation in Myxicola. Brain Res. 413:1987;185-188.
40. Shuaib A., Ijaz S., Kanthan R. Clomethiazole protects the brain in transient forebrain ischemia when used up to 4 h after the insult. Neurosci. Lett. 197:1995;109-112.
41. A. Shuaib, R. Mahmood, T. Wishart, R. Kanthan, M. Murabit, S. Ijaz, H. Miyashita, W. Howlett, Neuroprotective effects of lamotrigine in global ischemia in gerbils. A histological, in vivo microdialysis and behavioural study, Brain Res. 702 (1996) 199-206.
42. Shuaib A., Mazagri R., Ijaz S. GABA agonist 'muscimol' is neuroprotective in repetitive transient forebrain ischemia in gerbils. Exp. Neurol. 123:1993;284-288.
43. Shuaib A., Truelove D., Ijaz S., Kanthan R., Kalra J. The effect of post-ischemic hypothermia following repetitive cerebral ischemia in gerbils. Neurosci. Lett. 186:1995;165-168.
44. Siesjö B. Mechanisms of ischemic brain damage. Crit. Care Med. 16:1988;954-963.
45. Simpson R., O'Regan M., Perkins L., Phillis J. Excitatory transmitter amino acid release from the ischemic rat cerebral cortex: effects of adenosine receptor agonists and antagonists. J. Neurochem. 58:1992;1683-1690.
46. Suzuki S., Kawakami K., Nishimura S., Watanabe Y., Yagi K., Seino M., Miyamoto K. Zonisamide blocks T-type calcium channel in cultured neurons of rat cerebral cortex. Epilepsy Res. 12:1992;21-27.
47. Szatkowski M., Barbour B., Attwell D. Non-vesicular release of glutamate from glial cells by reversed electrogenic glutamate uptake. Nature. 348:1990;443-446.
48. Taft W., Clifton G., Blair R., Delorenzo R. Phenytoin protects against ischemia-produced neuronal cell death. Brain Res. 483:1989;143-148.
49. Valentino K., Newcomb R., Gadbois T., Singh T., Browersox S., Bitner S., Justice A., Yamashiro D., Hoffman B., Ciaranello R.et al. A selective N-type calcium channel antagonist protects against neuronal loss after global cerebral ischemia. Proc. Natl. Acad. Sci. USA. 90:1994;7894-7897.
50. Valtysson J., Hillered L., Andine P., Hagberg H., Persson L. Neuropathological endpoints in experimental stroke pharmacotherapy: the importance of both early and late evaluation. Acta Neurochir. 129:1994;58-63.
51. Wiard R., Dickerson M., Beek O., Norton R., Cooper B. Neuroprotective properties of the novel antiepileptic lamotrigine in a gerbil model of global cerebral ischemia. Stroke. 26:1995;466-472.
52. Whishaw I., Rod M., Auer N. Behavioural deficits revealed by multiple tests in rats with ischemic damage limited to half of the CA1 sector of the hippocampus. Brain Res. Bull. 34:1994;283-289.
53. Xie Y., Dengler K., Zacharias E., Wilffert B., Tegtmeier F. Effects of the sodium channel blocker tetrodotoxin (TTX) on cellular ion homeostasis in rat brain subjected to complete ischemia. Brain Res. 652:1994;216-224.